Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1

Status

Recruiting 3Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 5NIH 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gastrointestinal 164Breast 93Thoracic 37Genitourinary 33Gynecologic 28Sarcoma 25Head & Neck 23CNS 19Plasma cell 6Lymphoid 6Tumor-Agnostic 5Other solid neoplasm 4Dermatologic 3Other hematologic neoplasm 1Endocrine 1Classical hematology 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2Waldenstrom Macroglobulinemia 1Lymphoma, Mantle-Cell 1Lymphoma 1Hodgkin Disease 1

Interventions

Rituximab 1371Cyclophosphamide 1296Vincristine 662Doxorubicin 583Etoposide 525Prednisone 504Cytarabine 481fludarabine 461Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 254ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 227Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Neoadjuvant Therapy × Lymphoid × Clear all
NCT07259122 2025-12-02

ZBR in WM

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Not yet recruiting
43 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

NCT06664411 2025-08-19

Pola-ZR2P in Previously Untreated DLBCL

Navy General Hospital, Beijing

Phase 2 Recruiting
80 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT06665217 2025-08-14

G-Pola-ZLP in Diffuse Large B-Cell Lymphoma

Navy General Hospital, Beijing

Phase 2 Not yet recruiting
80 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04378647 2024-02-26

BRESELIBET

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Phase 2 Recruiting
150 enrolled
Lymphoid

Hodgkin Disease

NCT02858258 2017-12-19

ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma

European Mantle Cell Lymphoma Network

Phase 3 Recruiting
870 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT00003261 2013-09-20

Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma

National Cancer Institute (NCI)

Phase 2 Unknown
14 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡